SG11202113348UA - Cgrp antagonist compounds - Google Patents
Cgrp antagonist compoundsInfo
- Publication number
- SG11202113348UA SG11202113348UA SG11202113348UA SG11202113348UA SG11202113348UA SG 11202113348U A SG11202113348U A SG 11202113348UA SG 11202113348U A SG11202113348U A SG 11202113348UA SG 11202113348U A SG11202113348U A SG 11202113348UA SG 11202113348U A SG11202113348U A SG 11202113348UA
- Authority
- SG
- Singapore
- Prior art keywords
- antagonist compounds
- cgrp antagonist
- cgrp
- compounds
- antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1908420.1A GB201908420D0 (en) | 2019-06-12 | 2019-06-12 | Cgrp antagonist compounds |
PCT/GB2020/051428 WO2020249969A1 (en) | 2019-06-12 | 2020-06-12 | Cgrp antagonist compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202113348UA true SG11202113348UA (en) | 2021-12-30 |
Family
ID=67386295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202113348UA SG11202113348UA (en) | 2019-06-12 | 2020-06-12 | Cgrp antagonist compounds |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220306651A1 (en) |
EP (1) | EP3983416A1 (en) |
JP (1) | JP7553483B2 (en) |
KR (1) | KR20220020908A (en) |
CN (1) | CN114245798B (en) |
AU (1) | AU2020290734A1 (en) |
BR (1) | BR112021025071A2 (en) |
CA (1) | CA3143284A1 (en) |
GB (1) | GB201908420D0 (en) |
IL (1) | IL288876A (en) |
SG (1) | SG11202113348UA (en) |
WO (1) | WO2020249969A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602005010463D1 (en) * | 2004-10-13 | 2008-11-27 | Merck & Co Inc | CGRP RECEPTOR ANTAGONISTS |
GB0725103D0 (en) * | 2007-12-21 | 2008-01-30 | Glaxo Group Ltd | Novel compounds |
US8765759B2 (en) * | 2008-03-28 | 2014-07-01 | Merck Sharp & Dohme Corp. | Monocyclic CGRP receptor antagonists |
GB201519196D0 (en) | 2015-10-30 | 2015-12-16 | Heptares Therapeutics Ltd | CGRP Receptor Antagonists |
-
2019
- 2019-06-12 GB GBGB1908420.1A patent/GB201908420D0/en not_active Ceased
-
2020
- 2020-06-12 JP JP2021573851A patent/JP7553483B2/en active Active
- 2020-06-12 SG SG11202113348UA patent/SG11202113348UA/en unknown
- 2020-06-12 CA CA3143284A patent/CA3143284A1/en active Pending
- 2020-06-12 AU AU2020290734A patent/AU2020290734A1/en active Pending
- 2020-06-12 WO PCT/GB2020/051428 patent/WO2020249969A1/en unknown
- 2020-06-12 EP EP20734276.7A patent/EP3983416A1/en active Pending
- 2020-06-12 BR BR112021025071A patent/BR112021025071A2/en unknown
- 2020-06-12 CN CN202080057239.6A patent/CN114245798B/en active Active
- 2020-06-12 US US17/617,873 patent/US20220306651A1/en active Pending
- 2020-06-12 KR KR1020227001007A patent/KR20220020908A/en unknown
-
2021
- 2021-12-09 IL IL288876A patent/IL288876A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL288876A (en) | 2022-02-01 |
WO2020249969A1 (en) | 2020-12-17 |
US20220306651A1 (en) | 2022-09-29 |
BR112021025071A2 (en) | 2022-02-22 |
CN114245798B (en) | 2024-08-27 |
GB201908420D0 (en) | 2019-07-24 |
KR20220020908A (en) | 2022-02-21 |
CA3143284A1 (en) | 2020-12-17 |
EP3983416A1 (en) | 2022-04-20 |
AU2020290734A1 (en) | 2022-01-06 |
JP2022535993A (en) | 2022-08-10 |
JP7553483B2 (en) | 2024-09-18 |
CN114245798A (en) | 2022-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279363A (en) | Pcsk9 antagonist compounds | |
PL3844147T3 (en) | Compounds | |
GB201905721D0 (en) | Compounds | |
IL289252A (en) | Ep2 antagonist | |
GB201905552D0 (en) | Antagonists | |
IL300211A (en) | Antagonist compounds | |
GB201817047D0 (en) | H4 antagonist compounds | |
GB201910305D0 (en) | Compounds | |
GB202019622D0 (en) | Antagonist compounds | |
GB201908536D0 (en) | Compounds | |
GB201908171D0 (en) | Compounds | |
IL281448A (en) | Prodrugs of cgrp antagonists | |
SG11202113348UA (en) | Cgrp antagonist compounds | |
SG11202113345WA (en) | Cgrp antagonist compounds | |
GB201910304D0 (en) | Compounds | |
GB201908095D0 (en) | Carboxy-MIDA-boronate compounds | |
GB201910865D0 (en) | Antagonist compounds | |
GB201904158D0 (en) | Antagonist compounds | |
GB202019922D0 (en) | Antagonist compounds | |
GB201910526D0 (en) | Antagonist | |
GB201812604D0 (en) | Antagonist compounds | |
GB201909500D0 (en) | Antagonist | |
GB202011892D0 (en) | Antagonist compounds | |
GB202006823D0 (en) | Antagonist compounds | |
GB202000906D0 (en) | Antagonist |